Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart

Ischemia/reperfusion (I/R) of the heart becomes injurious when duration of the ischemic insult exceeds a certain threshold (approximately ≥20 min). Mitochondrial bound hexokinase II (mtHKII) protects against I/R injury, with the amount of mtHKII correlating with injury. Here, we examine whether mtHK...

Full description

Saved in:
Bibliographic Details
Published in:Journal of physiology and biochemistry Vol. 73; no. 3; pp. 323 - 333
Main Authors: Nederlof, Rianne, Gürel-Gurevin, Ebru, Eerbeek, Otto, Xie, Chaoqin, Deijs, G. Sjoerd, Konkel, Moritz, Hu, Jun, Weber, Nina C., Schumacher, Cees A., Baartscheer, Antonius, Mik, Egbert G., Hollmann, Markus W., Akar, Fadi G., Zuurbier, Coert J.
Format: Journal Article
Language:English
Published: Dordrecht Springer Netherlands 01-08-2016
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ischemia/reperfusion (I/R) of the heart becomes injurious when duration of the ischemic insult exceeds a certain threshold (approximately ≥20 min). Mitochondrial bound hexokinase II (mtHKII) protects against I/R injury, with the amount of mtHKII correlating with injury. Here, we examine whether mtHKII can induce the transition from non-injurious to injurious I/R, by detaching HKII from mitochondria during a non-injurious I/R interval. Additionally, we examine possible underlying mechanisms (increased reactive oxygen species (ROS), increased oxygen consumption (MVO 2 ) and decreased cardiac energetics) associated with this transition. Langendorff perfused rat hearts were treated for 20 min with saline, TAT-only or 200 nM TAT-HKII, a peptide that translocates HKII from mitochondria. Then, hearts were exposed to non-injurious 15-min ischemia, followed by 30-min reperfusion. I/R injury was determined by necrosis (LDH release) and cardiac mechanical recovery. ROS were measured by DHE fluorescence. Changes in cardiac respiratory activity (cardiac MVO 2 and efficiency and mitochondrial oxygen tension (mitoPO 2 ) using protoporphyrin IX) and cardiac energetics (ATP, PCr, ∆G ATP ) were determined following peptide treatment. When exposed to 15-min ischemia, control hearts had no necrosis and 85% recovery of function. Conversely, TAT-HKII treatment resulted in significant LDH release and reduced cardiac recovery (25%), indicating injurious I/R. This was associated with increased ROS during ischemia and reperfusion. TAT-HKII treatment reduced MVO 2 and improved energetics (increased PCr) before ischemia, without affecting MVO 2 /RPP ratio or mitoPO 2 . In conclusion, a reduction in mtHKII turns non-injurious I/R into injurious I/R. Loss of mtHKII was associated with increased ROS during ischemia and reperfusion, but not with increased MVO 2 or decreased cardiac energetics before damage occurs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1138-7548
1877-8755
DOI:10.1007/s13105-017-0555-3